Great news.
Now for the cornerstone partner.
Way too early to sell the farm...but you just never know how desperate Big Pharma is for pipeline, considering ATL has potential beyond just DMD.
Now the tox study is complete, wonder if the MS program gets dusted off too?
.
Ann: Phase IIb study of ATL1102 in DMD completes recruitment, page-15
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.87M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3790595 | 1.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 466666 | 3 |
View Market Depth
| Last trade - 10.04am 25/06/2025 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable